Bifogade filer
PDF
Kurs
-8,67%
Likviditet
51,2 MSEK
Kalender
| Tid* | ||
| 2025-11-04 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-08-19 | 07:00 | Kvartalsrapport 2025-Q2 |
| 2025-06-12 | N/A | X-dag ordinarie utdelning OSSD 0.00 SEK |
| 2025-06-11 | N/A | Årsstämma |
| 2025-05-06 | 07:00 | Kvartalsrapport 2025-Q1 |
| 2025-02-04 | - | Bokslutskommuniké 2024 |
| 2024-12-18 | - | Extra Bolagsstämma 2024 |
| 2024-11-12 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-20 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-22 | - | X-dag ordinarie utdelning OSSD 0.00 SEK |
| 2024-05-21 | - | Årsstämma |
| 2024-05-14 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-06 | - | Bokslutskommuniké 2023 |
| 2023-11-21 | - | Kvartalsrapport 2023-Q3 |
| 2023-10-16 | - | Extra Bolagsstämma 2023 |
| 2023-08-22 | - | Kvartalsrapport 2023-Q2 |
| 2023-06-01 | - | X-dag ordinarie utdelning OSSD 0.00 SEK |
| 2023-05-31 | - | Årsstämma |
| 2023-05-23 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-21 | - | Bokslutskommuniké 2022 |
| 2022-11-22 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-23 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-03 | - | X-dag ordinarie utdelning OSSD 0.00 SEK |
| 2022-06-02 | - | Årsstämma |
| 2022-05-24 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-22 | - | Bokslutskommuniké 2021 |
| 2021-11-17 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-18 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-20 | - | X-dag ordinarie utdelning OSSD 0.00 SEK |
| 2021-05-19 | - | Årsstämma |
| 2021-05-12 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-09 | - | Extra Bolagsstämma 2021 |
| 2021-02-11 | - | Bokslutskommuniké 2020 |
| 2020-11-11 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-19 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-22 | - | X-dag ordinarie utdelning OSSD 0.00 SEK |
| 2020-05-20 | - | Årsstämma |
| 2020-05-13 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-13 | - | Bokslutskommuniké 2019 |
| 2019-11-19 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-21 | - | Kvartalsrapport 2019-Q2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
OssDsign AB (publ) today announces a change of Certified Adviser from Erik Penser Bank AB to Carnegie Investment Bank AB.
OssDsign has entered into an agreement with Carnegie Investment Bank AB regarding the position of Certified Adviser. Carnegie Investment Bank AB will take over as Certified Adviser as of today.
For further information, please contact:
Morten Henneveld, CEO, OssDsign AB
Tel: +46 73 382 43 90, email: morten.henneveld@ossdsign.com
Certified Adviser
The Company's Certified Adviser is Carnegie Investment Bank AB (publ)
About OssDsign
OssDsign is a developer and global provider of next generation bone replacement products. Based on cutting edge material science, the company develops and markets products that support the body's own healing capabilities and thereby improve the clinical outcome in a wide range of orthopedic areas with high medical needs. With a product portfolio consisting of patient-specific implants for cranial surgeries and an off-the-shelf synthetic bone graft for spine surgeries, OssDsign give patients back the life they deserve. The company has a strong commercial presence in the U.S., Europe and selected Asian countries. OssDsign's share is traded on Nasdaq First North Growth Market in Stockholm, Sweden.